Education
About Us
Working with TipRanks
Follow Us
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
RESEARCH TOOLSreports
INTS Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INTS Stock 12 Month Forecast
Average Price Target
$6.25
▲(220.51% Upside)
| Highest Price Target$8.50 | Average Price Target$6.25 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Benchmark Co.
Reiterated
03/19/25
Alliance Global Partners
Initiated
01/13/25
H.C. Wainwright
$5
Buy
156.41%
Upside
Reiterated
11/21/24
Promising Clinical Progress and Financial Stability Drive Positive Outlook for Intensity Therapeutics, Inc.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Benchmark Co.
Reiterated
03/19/25
Alliance Global Partners
Initiated
01/13/25
H.C. Wainwright
$5
Buy
156.41%
Upside
Reiterated
11/21/24
Promising Clinical Progress and Financial Stability Drive Positive Outlook for Intensity Therapeutics, Inc.
INTS Analyst Recommendation Trends
Rating
Aug 23
Oct 24
Nov 24
Jan 25
Mar 25
Strong Buy
2
3
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
INTS Financial Forecast
INTS Stock Forecast FAQ
What is INTS’s average 12-month price target, according to analysts?
Based on analyst ratings, Intensity Therapeutics, Inc.’s 12-month average price target is $6.25.
What is INTS’s upside potential, based on the analysts’ average price target?
Intensity Therapeutics, Inc. has 220.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INTS a Buy, Sell or Hold?
Intensity Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Intensity Therapeutics, Inc.’s price target?
The average price target for Intensity Therapeutics, Inc. is $6.25. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.50 ,the lowest forecast is $4.00. The average price target represents 220.51% Increase from the current price of $1.95.
The highest analyst price target is $8.50 ,the lowest forecast is $4.00. The average price target represents 220.51% Increase from the current price of $1.95.
What do analysts say about Intensity Therapeutics, Inc.?
Intensity Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of INTS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.